Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
• The global Tagrisso (Osimertinib) market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Tagrisso (Osimertinib) market is expected to reach the value of US$ XX Million by the end of 2031
Tagrisso (Osimertinib) Market Overview
Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.
This report studies and analyses global Tagrisso (Osimertinib) status and future trends, helping the client to determine the Tagrisso (Osimertinib) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Tagrisso (Osimertinib). It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.
Tagrisso (Osimertinib) Market Key Takeaways
(1) Global Tagrisso (Osimertinib) market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Tagrisso (Osimertinib) sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Tagrisso (Osimertinib) sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Tagrisso (Osimertinib) key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Tagrisso (Osimertinib) key producing regions, capacity, production, and year-over-year growth
(6) Tagrisso (Osimertinib) industry chains, upstream, midstream, and downstream
Tagrisso (Osimertinib) Market: Key Players
The competitive landscape of the Tagrisso (Osimertinib) Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Tagrisso (Osimertinib) Market. Some of the major players operating in the Tagrisso (Osimertinib) Market are:
- AstraZeneca
- Incepta Pharmaceuticals Ltd
- Lonza AG
- Everest Pharmaceuticals
- Beacon Pharmaceuticals Limited
- Drug International Limited
Market IntelliX's study on the Tagrisso (Osimertinib) market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Tagrisso (Osimertinib) Market by Type [Analysis by Value from 2020 to 2031]:
- 40 mg
- 80 mg
Tagrisso (Osimertinib) Market by Application [Analysis by Value from 2020 to 2031]:
- Locally Advanced NSCLC
- Metastatic NSCLC
- Other
Tagrisso (Osimertinib) Market by Region [Analysis by Value from 2020 to 2031]:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America (Brazil, Argentina and Colombia etc.)
- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Tagrisso (Osimertinib) Market Report Includes:
Chapter 1: To describe Tagrisso (Osimertinib) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Tagrisso (Osimertinib) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 3: China Tagrisso (Osimertinib) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024
Chapter 4: Global key producing regions of Tagrisso (Osimertinib) , percent & CAGR, 2020 - 2031
Chapter 5: Tagrisso (Osimertinib) industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Tagrisso (Osimertinib) Definition
1.2 Global Tagrisso (Osimertinib) Market Size and Forecast
1.2.1 By Consumption Value, Global Tagrisso (Osimertinib) Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Tagrisso (Osimertinib) Market Size, 2020-2031
1.2.3 Global Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031
1.3 China Tagrisso (Osimertinib) Market Size and Forecast
1.3.1 By Consumption Value, China Tagrisso (Osimertinib) Market Size, 2020-2031
1.3.2 By Sales Quantity, China Tagrisso (Osimertinib) Market Size, 2020-2031
1.3.3 China Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031
1.4 Share of China Tagrisso (Osimertinib) Market with Respect to the Global Market
1.4.1 By Consumption Value, China Tagrisso (Osimertinib) Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Tagrisso (Osimertinib) Market Share in Global, 2020-2031
1.4.3 Tagrisso (Osimertinib) Market Size: China VS Global, 2020-2031
1.5 Tagrisso (Osimertinib) Market Dynamics
1.5.1 Tagrisso (Osimertinib) Market Drivers
1.5.2 Tagrisso (Osimertinib) Market Restraints
1.5.3 Tagrisso (Osimertinib) Industry Trends
1.5.4 Tagrisso (Osimertinib) Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Tagrisso (Osimertinib), Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Tagrisso (Osimertinib), Global Market Share by Company, 2020-2025
2.3 Tagrisso (Osimertinib) Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Tagrisso (Osimertinib) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Tagrisso (Osimertinib) Concentration Ratio
2.6 Global Tagrisso (Osimertinib) Mergers & Acquisitions, Expansion Plans
2.7 Global Tagrisso (Osimertinib) Manufacturers Product Type
2.8 Head Office and Tagrisso (Osimertinib) Production Site of Key Manufacturer
2.9 Tagrisso (Osimertinib) Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Tagrisso (Osimertinib), China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Tagrisso (Osimertinib), China Market Share by Company, 2020-2025
3.3 China Tagrisso (Osimertinib) Tagrisso (Osimertinib) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Tagrisso (Osimertinib) Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Tagrisso (Osimertinib) Capacity by Region
4.3 Global Tagrisso (Osimertinib) Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Tagrisso (Osimertinib) Production by Region, 2020-2031
4.5 Global Tagrisso (Osimertinib) Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
5.1 Tagrisso (Osimertinib) Industry Chain
5.2 Tagrisso (Osimertinib) Upstream Analysis
5.2.1 Tagrisso (Osimertinib) Core Raw Materials
5.2.2 Main Manufacturers of Tagrisso (Osimertinib) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Tagrisso (Osimertinib) Production Mode
5.6 Tagrisso (Osimertinib) Procurement Model
5.7 Tagrisso (Osimertinib) Industry Sales Model and Sales Channels
5.7.1 Tagrisso (Osimertinib) Sales Model
5.7.2 Tagrisso (Osimertinib) Typical Distributors
6 Sights by Product Type
6.1 Tagrisso (Osimertinib) Classification
6.1.1 40 mg
6.1.2 80 mg
6.2 by Type, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031
6.4 by Type, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031
6.5 by Type, Global Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031
7 Sights by Application
7.1 Tagrisso (Osimertinib) Segment by Application
7.1.1 Locally Advanced NSCLC
7.1.2 Metastatic NSCLC
7.1.3 Other
7.2 by Application, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031
7.4 by Application, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031
7.5 by Application, Global Tagrisso (Osimertinib) Price, 2020-2031
8 Sales Sights by Region
8.1 By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031
8.3 By Region, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Tagrisso (Osimertinib) Market Size Market Share
8.5 Europe
8.5.1 Europe Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Tagrisso (Osimertinib) Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Tagrisso (Osimertinib) Market Size Market Share
8.7 South America
8.7.1 South America Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Tagrisso (Osimertinib) Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Tagrisso (Osimertinib) Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031
9.3 By Country, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Tagrisso (Osimertinib) Market Size, 2020-2031
9.4.2 by Type, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Tagrisso (Osimertinib) Market Size, 2020-2031
9.5.2 by Type, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Tagrisso (Osimertinib) Market Size, 2020-2031
9.6.2 by Type, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Tagrisso (Osimertinib) Market Size, 2020-2031
9.7.2 by Type, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Tagrisso (Osimertinib) Market Size, 2020-2031
9.8.2 by Type, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Tagrisso (Osimertinib) Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Tagrisso (Osimertinib) Market Size, 2020-2031
9.10.2 by Type, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Tagrisso (Osimertinib) Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.1.2 AstraZeneca Tagrisso (Osimertinib) Models, Specifications, and Application
10.1.3 AstraZeneca Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 AstraZeneca Company Profile and Main Business
10.1.5 AstraZeneca Recent Developments
10.2 Incepta Pharmaceuticals Ltd
10.2.1 Incepta Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Models, Specifications, and Application
10.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Incepta Pharmaceuticals Ltd Company Profile and Main Business
10.2.5 Incepta Pharmaceuticals Ltd Recent Developments
10.3 Lonza AG
10.3.1 Lonza AG Company Information, Head Office, Market Area, and Industry Position
10.3.2 Lonza AG Tagrisso (Osimertinib) Models, Specifications, and Application
10.3.3 Lonza AG Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Lonza AG Company Profile and Main Business
10.3.5 Lonza AG Recent Developments
10.4 Everest Pharmaceuticals
10.4.1 Everest Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Everest Pharmaceuticals Tagrisso (Osimertinib) Models, Specifications, and Application
10.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Everest Pharmaceuticals Company Profile and Main Business
10.4.5 Everest Pharmaceuticals Recent Developments
10.5 Beacon Pharmaceuticals Limited
10.5.1 Beacon Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
10.5.2 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Models, Specifications, and Application
10.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Beacon Pharmaceuticals Limited Company Profile and Main Business
10.5.5 Beacon Pharmaceuticals Limited Recent Developments
10.6 Drug International Limited
10.6.1 Drug International Limited Company Information, Head Office, Market Area, and Industry Position
10.6.2 Drug International Limited Tagrisso (Osimertinib) Models, Specifications, and Application
10.6.3 Drug International Limited Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Drug International Limited Company Profile and Main Business
10.6.5 Drug International Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Tagrisso (Osimertinib) Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Tagrisso (Osimertinib) Market Restraints
Table 3. Tagrisso (Osimertinib) Market Trends
Table 4. Tagrisso (Osimertinib) Industry Policy
Table 5. Global Tagrisso (Osimertinib) Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Tagrisso (Osimertinib) Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Tagrisso (Osimertinib) Sales Quantity by Company, (2020-2025) & (K Pcs), Ranked Based on Sales in 2024
Table 8. Global Tagrisso (Osimertinib) Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 9. Global Tagrisso (Osimertinib) Average Selling Price (ASP) by Company, (2020-2025) & (US$/Pcs)
Table 10. Global Tagrisso (Osimertinib) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Tagrisso (Osimertinib) Mergers & Acquisitions, Expansion Plans
Table 12. Global Tagrisso (Osimertinib) Manufacturers Product Type
Table 13. Head Office and Tagrisso (Osimertinib) Production Site of Key Manufacturer
Table 14. Tagrisso (Osimertinib) Capacity of Major Manufacturers and Future Plan
Table 15. China Tagrisso (Osimertinib) Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 16. China Tagrisso (Osimertinib) Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 17. China Tagrisso (Osimertinib) Sales Quantity by Company, (2020-2025) & (K Pcs), Ranked Based on Sales in 2024
Table 18. China Tagrisso (Osimertinib) Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 19. Global Tagrisso (Osimertinib) Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Pcs)
Table 20. Global Tagrisso (Osimertinib) Production by Region, 2020-2025, (K Pcs)
Table 21. Global Tagrisso (Osimertinib) Production Forecast by Region, 2026-2031, (K Pcs)
Table 22. Global Key Players of Tagrisso (Osimertinib) Upstream (Raw Materials)
Table 23. Global Tagrisso (Osimertinib) Typical Customers
Table 24. Tagrisso (Osimertinib) Typical Distributors
Table 25. by Type, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 26. by Application, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 27. By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 28. By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031, US$ Million
Table 29. By Region, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Table 30. By Country, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 31. By Country, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031, US$ Million
Table 32. By Country, Global Tagrisso (Osimertinib) Consumption Value Market Share, 2020-2031
Table 33. By Country, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Table 34. By Country, Global Tagrisso (Osimertinib) Sales Quantity Market Share, 2020-2031
Table 35. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 36. AstraZeneca Tagrisso (Osimertinib) Models, Specifications, and Application
Table 37. AstraZeneca Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 38. AstraZeneca Company Profile and Main Business
Table 39. AstraZeneca Recent Developments
Table 40. Incepta Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
Table 41. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Models, Specifications, and Application
Table 42. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 43. Incepta Pharmaceuticals Ltd Company Profile and Main Business
Table 44. Incepta Pharmaceuticals Ltd Recent Developments
Table 45. Lonza AG Company Information, Head Office, Market Area, and Industry Position
Table 46. Lonza AG Tagrisso (Osimertinib) Models, Specifications, and Application
Table 47. Lonza AG Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 48. Lonza AG Company Profile and Main Business
Table 49. Lonza AG Recent Developments
Table 50. Everest Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 51. Everest Pharmaceuticals Tagrisso (Osimertinib) Models, Specifications, and Application
Table 52. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 53. Everest Pharmaceuticals Company Profile and Main Business
Table 54. Everest Pharmaceuticals Recent Developments
Table 55. Beacon Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
Table 56. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Models, Specifications, and Application
Table 57. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 58. Beacon Pharmaceuticals Limited Company Profile and Main Business
Table 59. Beacon Pharmaceuticals Limited Recent Developments
Table 60. Drug International Limited Company Information, Head Office, Market Area, and Industry Position
Table 61. Drug International Limited Tagrisso (Osimertinib) Models, Specifications, and Application
Table 62. Drug International Limited Tagrisso (Osimertinib) Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025
Table 63. Drug International Limited Company Profile and Main Business
Table 64. Drug International Limited Recent Developments
List of Figures
Figure 1. Tagrisso (Osimertinib) Picture
Figure 2. Global Tagrisso (Osimertinib) Consumption Value, (US$ million) & (2020-2031)
Figure 3. Global Tagrisso (Osimertinib) Sales Quantity, (K Pcs) & (2020-2031)
Figure 4. Global Tagrisso (Osimertinib) Average Selling Price (ASP), (2020-2031) & (US$/Pcs)
Figure 5. China Tagrisso (Osimertinib) Consumption Value, (US$ million) & (2020-2031)
Figure 6. China Tagrisso (Osimertinib) Sales Quantity (K Pcs) & (2020-2031)
Figure 7. China Tagrisso (Osimertinib) Average Selling Price (ASP), (US$/Pcs) & (2020-2031)
Figure 8. By Consumption Value, China Tagrisso (Osimertinib) Market Share of Global, 2020-2031
Figure 9. By Sales Quantity, China Tagrisso (Osimertinib) Market Share of Global, 2020-2031
Figure 10. Global Tagrisso (Osimertinib) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Tagrisso (Osimertinib) Key Participants, Market Share, 2024
Figure 12. Global Tagrisso (Osimertinib) Capacity, Production and Capacity Utilization, 2020-2031
Figure 13. Global Tagrisso (Osimertinib) Capacity Market Share by Region, 2024 VS 2031
Figure 14. Global Tagrisso (Osimertinib) Production Market Share & Forecast by Region, 2020-2031
Figure 15. Tagrisso (Osimertinib) Industry Chain
Figure 16. Tagrisso (Osimertinib) Procurement Model
Figure 17. Tagrisso (Osimertinib) Sales Model
Figure 18. Tagrisso (Osimertinib) Sales Channels, Direct Sales, and Distribution
Figure 19. 40 mg
Figure 20. 80 mg
Figure 21. by Type, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031, US$ Million
Figure 22. by Type, Global Tagrisso (Osimertinib) Consumption Value Market Share, 2020-2031
Figure 23. by Type, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 24. by Type, Global Tagrisso (Osimertinib) Sales Quantity Market Share, 2020-2031
Figure 25. by Type, Global Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031, (US$/Pcs)
Figure 26. Locally Advanced NSCLC
Figure 27. Metastatic NSCLC
Figure 28. Other
Figure 29. by Application, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031, US$ Million
Figure 30. by Application, Global Tagrisso (Osimertinib) Revenue Market Share, 2020-2031
Figure 31. by Application, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 32. by Application, Global Tagrisso (Osimertinib) Sales Quantity Market Share, 2020-2031
Figure 33. by Application, Global Tagrisso (Osimertinib) Price, 2020-2031, (US$/Pcs)
Figure 34. By Region, Global Tagrisso (Osimertinib) Consumption Value Market Share, 2020-2031
Figure 35. By Region, Global Tagrisso (Osimertinib) Sales Quantity Market Share, 2020-2031
Figure 36. North America Tagrisso (Osimertinib) Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 37. By Country, North America Tagrisso (Osimertinib) Consumption Value Market Share, 2024
Figure 38. Europe Tagrisso (Osimertinib) Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 39. By Country, Europe Tagrisso (Osimertinib) Consumption Value Market Share, 2024
Figure 40. Asia Pacific Tagrisso (Osimertinib) Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 41. By Country/Region, Asia Pacific Tagrisso (Osimertinib) Consumption Value Market Share, 2024
Figure 42. South America Tagrisso (Osimertinib) Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 43. By Country, South America Tagrisso (Osimertinib) Consumption Value Market Share, 2024
Figure 44. Middle East & Africa Tagrisso (Osimertinib) Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 45. United States Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 46. by Type, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 47. by Application, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 48. Europe Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 49. by Type, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 50. by Application, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 51. China Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 52. by Type, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 53. by Application, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 54. Japan Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 55. by Type, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 56. by Application, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 57. South Korea Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 58. by Type, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 59. by Application, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 60. Southeast Asia Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 61. by Type, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 62. by Application, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 63. India Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 64. by Type, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 65. by Application, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 66. Middle East & Africa Tagrisso (Osimertinib) Sales Quantity, 2020-2031, (K Pcs)
Figure 67. by Type, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 68. by Application, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up Approaches
Figure 72. Top-down Approaches
Research Methodology:
Tagrisso (Osimertinib) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|